Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

203.34
+0.24000.12%
Pre-market: 205.602.26+1.11%04:01 EDT
Volume:1.48M
Turnover:301.21M
Market Cap:10.45B
PE:32.22
High:205.81
Open:201.84
Low:201.12
Close:203.10
52wk High:217.12
52wk Low:149.09
Shares:51.40M
Float Shares:51.40M
Volume Ratio:0.77
T/O Rate:2.87%
Dividend:0.35
Dividend Rate:0.17%
EPS(TTM):6.31
EPS(LYR):35.34
ROE:24.54%
ROA:0.10%
PB:1.28
PE(LYR):5.75

Loading ...

Vertex appoints Saha to Board of Directors

TIPRANKS
·
Oct 01

Press Release: Vertex Appoints DataRobot CEO Debanjan Saha to Board of Directors

Dow Jones
·
Oct 01

Regeneron Pharmaceuticals, Inc. : Argus Research Raises to Buy from Hold

THOMSON REUTERS
·
Oct 01

Stocks to Watch: Micron, Alphabet, Sanofi, Nu Holdings

Dow Jones
·
Oct 01

Sanofi’s Regeneron Fix Requires Extra Shot of M&A

Reuters
·
Oct 01

Sanofi CEO Takes First Step Toward Addressing Long-Term Outlook

Dow Jones
·
Oct 01

Sanofi to Get Pipeline Boost from Expanded Regeneron Alliance

Dow Jones
·
Oct 01

Sanofi, Regeneron Expand Tie-up with $8 Billion Drug-Development Deal, Settle Legal Dispute

Reuters
·
Oct 01

Regeneron, Sanofi Expand Antibody Alliance with USD 1 Billion Upfront Payment

Reuters
·
Oct 01

Sanofi, Regeneron Expand Antibody Alliance in Long-Acting Immunology Programs for USD 1 Billion Upfront

Reuters
·
Oct 01

Sanofi - Companies to Equally Share Development and Commercialization Costs, as Well as Any Future Profits

THOMSON REUTERS
·
Oct 01

Sanofi - and Regeneron Settle Prior Collaboration-Related Litigation

THOMSON REUTERS
·
Oct 01

Sanofi - Regeneron May Include Sanofi's Lunsekimig Therapy After Phase 3 Studies

THOMSON REUTERS
·
Oct 01

Sanofi - Regeneron to Receive $1 Bln Upfront with Potential for up to an Additional $7 Bln in Future Milestone Payments

THOMSON REUTERS
·
Oct 01

Arovella Nears First Patient Dosing in Pivotal ALA-101 Cell Therapy Trial

TIPRANKS
·
Oct 01

The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind

Dow Jones
·
Oct 01

Regeneron Drug Halves Muscle Loss in Combination with Novo's Semaglutide in Trial

Reuters
·
Oct 01

Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Oct 01

Moderna Inc. Stock Sheds 5.4%, Underperforms Peers

Dow Jones
·
Oct 01

Regeneron Links 2026 CEO, CSO PSU Awards to FDA Filings, Approvals and New-Product Revenue Targets Through 2035

Reuters
·
Oct 01